Category Archives: Medical Research

Why Is Our Health Care is So Expensive? Someone Finally Got It!

In the February 7th, 2008 issue of the New England Journal of Medicine, page 549, a perspective written by Robert Kuttner should be mandatory reading for every politician, doctor, patient and anyone else who avails themselves or is involved in the United States health care system. In this brilliantly written article, Mr Kuttner, co-editor of the American Prospect, talks about the real reason our health care system is so ridiculously expensive. 

He writes “The extreme failure of the United States to contain medical costs results primarily from our unique, pervasice commercialization. The dominance of for-profit insurance and pharmaceutical companies, a new wave of investor-owned specialty hospitals, and profit-maximizing behavior even by nonprofit players raise costs and distort resource allocation.” Basically these profit hungry organizations cost you the patient between a staggering 400-500 billion dollars annually.

His comments and insight into the reasons why market optimization and competition does not mean greater efficiency in delivering health care and does not lower cost as with other industries is a must read. Do whatever you have to, to get a hold of this article.

His last paragraph was so telling. “Sometimes, we Americans do the right thing only after having exhausted all other alternatives. It remains to be seen how much exhaustion the health care system will suffer before we turn to national health insurance.” I have always been against this idea until I read this article. Maybe it is time to stop the greed and redo our failing and overly expensive health care system.

My Book is Out and Available

My book, Achieving Victory Over a Toxic World is now available through multiple outlets. It is the story of a child, my daughter, and her battle with a rare type of epilepsy, given little chance of recovery by the medical world, but through it all she has made it through, not perfectly, with the ability to live a normal life.

It also deals with what I believe caused her disorder, environmental toxicity. We are polluting our world at a staggering ratewhich is causing epidemics of diseases unheard of in human history. Big corporations would want you to believe this is not happening but my book shows you the truth.

The scariest part of my research delved into the effect these toxins are having on our most vunerable citizens, our children, and the up coming generations. In the final two parts of the book, I give you real world ideas on how to cope with the toxins and how you can begin the movement toward changing our world before it is too late. The increase in the rate of autism, asthma, epilepsy, ADHD, childhood cancers, cannot be explained by a “genetic epidemic”. We are poisoning ourselves and we can change that.

To order the book, you can go to either Amazon.com, Barnes and Noble.com or for faster service my publisher –  AuthorHouse’s web site . This book represents my 20+ years of research along with the passion that comes with fighting for a daughter’s life. I can guarantee one thing about the book and that is it will move you, both emotionally and physically to help us change the world.

Book Cover Picture

Allergies and Toxicity in Children – A Real Dilemma

Robyn O’Brien, a mother from Boulder, Colorado has taken up the battle against the people who would lead you to believe that environmental toxins and genetically modified foods have nothing to do with the explosion of allergies in children (among other health issues). Having just gotten off the phone with her, I noted a passion to tell the world about this issue and to educate the mother out there as to the growing problem affectin so many of them. Her website Allergy Kids is full of useful information about this important issue.

The more toxic our environment, the more damage will be done to our children and almost more importantly, their children. People like Robyn are the ones who will shake up this world and force the changes necessary to protect ourselves and kids. Please visit her site today.

The Deceit Just Keeps Getting Deeper

Just when you thought it couldn’t get any lower, it does. A report published on the Nature magazine website claims that Dr. Steven M. Haffner of the University of Texas Health Science Center in San Antonio, forwarded a report to drug manufacturer GlaxoSmithKline warning them about a paper that was about to be published by the New England Journal of Medicine (NEJM) critical of their blockbuster (blockbuster meaning big money maker) drug Avandia. He was supposed to be reviewing the paper and it is highly unethical and against NEJM rules to let anyone else see a paper being reviewed.

To see the full extent of the problem, go to this link at the New York Times. My question is, when do we put a stop to this unbridled greed and deceit?

Antidepressants – Hidden Drug Trials Show Negative Results

It almost seems to be an everyday issue, but more and more we see how drug trials that don’t show benefits are being either ignored, hidden or modified by the pharmaceutical industry. In a review of the studies on 12 antidepressant drugs, researchers led by Erick H. Turner found that 31% of the studies on these drugs went unpublished and the majority were negative or were conveyed to have a positive outcome which was contrary to the data. The paper was published in the New England Journal of Medicine, in their January 17, 2008 issue. What was truly remarkable was how much the perceived benefits of the drugs were changed because of the lack of publication of all of the data. According to the authors, if you looked at the published research, the antidepressant drugs had positive outcomes 94% of the time. If you include the unpublished research that number drops to a mere 51%. This is a huge difference and should make everyone think twice before agreeing to be put on the medications or at least safer, alternatives should be investigated first.

According to the papers conclusion, “We cannot determine whether the bias observed resulted from a failure to submit manuscripts on the part of authors and sponsors, from decisions by journal editors and reviewers not to publish, or both. Selective reporting of clinical trial results may have adverse consequences for researchers, study participants, health care professionals, and patients.” In my opinion, it is the sponsors who are probably most likely to apply pressure to stop publication. This would mean that the pharmaceutical industry is to blame. We need to take research on drug efficacy out of their hands and into the hands of real researchers without the onus of pressure and conflict of interest.

Why is this so damaging? When you do a search on meta-analysis of antidepressant drugs, you find a number that show how beneficial the drugs are, like the one by Drs. Dubika, Hadley and Roberts entitled, “Suicidal behaviour in youths with depression treated with new-generation antidepressants” published in the British Journal of Psychiatry in 2006. Would that study’s conclusion, which is that “Antidepressants may cause a small short-term risk of self-harm or suicidal events in children and adolescents with major depressive disorder” have changed to a large short-term risk or a small long-term risk or maybe worst case scenario, a large long-term risk? Chances are, based on the Turner paper that the answer is yes, the results would have changed but by how much, we cannot tell.

What we can say is that there is a major problem that needs a solution and it has to come sooner than later. How many of us are on medications that may not be helping us or maybe damaging our health and that of our loved ones?
So what do we do about it? Determine biochemical imbalances and toxicity influences on behavior as well as inflammatory processes that have been shown to cause depression in people for decades. The research exists but it is being downplayed by greedy pharmaceutical giants whose obvious intention is to make money at all costs and deflect criticism and downgrade safe alternatives.

Tomorrow, I will discuss a few tests I think are extremely helpful in working with mild to moderate depression in both adults and children.

Does Ethics Play a Role in Drug Trials Anymore?

In the January 19, 2008 issue of the British medical journal The Lancet, author Samuel Lowenberg brings up a number of serious questions relating to ethics and drug trials done by the pharmaceutical industry. After reading his brief two page review, it is apparent that a major overhaul in the way clinical trials are done is in order. The trail of abuse is international in scope and has possibly caused the deaths of innocent children.

According to Tikki Pang, the World Health Organization’s director of Research Policy and Cooperation, “The trials that are being done overseas by drug companies are in a sense secret, because they do not share the information, they site confidentiality and patient protection.” He further goes on to say “Anecdotally, we have heard many, many instances in India, China and other countries of the possibility of ethical safeguards not being followed.” In Nigeria, a number of children died of an experimental anti-meningitis drug Trovan and Pfizer, according to a lawsuit, destroyed data from the trial and gave some of the children a dangerously low dose of Rocephin, a known treatment for meningitis.

It is time for Congress to enact a bill demanding that all drug trial, in the U.S. or abroad, be registered and the results must be shared with the FDA regardless of outcome. The data then must be shared with the public without prejudice and in a timely manner. The nonsense that is pharmaceutical research has got to change. People’s health is at risk and lives are at stake. They are treating third world people like lab rats and this has got to stop.

Cholesterol Lowering Drugs are Worthless in Most Cases – Part Three

Before I get into today’s discussion on inflammation, please go to this link put up by Chance News, a group dedicated to reviewing information about the use of statistics in the news. They review the cholesterol news and and the statistics behind it. Go down halfway down the page to see the report.

Inflammation. That is the key driver of many disease progressions. From arthritis to coronary heart disease and from cancer to many neurological disorders, if you control inflammation, you control the disease. Two things are important in determining what to do when it comes to your, or your patient’s inflammatory issues. First is proper laboratory testing is lifestyle changes.

The tenet of biochemical individuality is that each person must be dealt with as a unique being. By suggesting that everyone who has a risk of coronary heart disease (CHD) should take one drug or one supplement is an insult to Dr. Roger Williams concept. The only way to determine what is going on is to do the appropriate lab tests.

When looking for markers of inflammation as they relate to coronary heart disease, one jumps out as being a primary marker and that is C-Reactive Protein. CRP is a protein produced by the liver and is increased during inflammatory processes. People with elevated levels are more likely to have a coronary event than people with low levels. It is important to note that a single high reading is not a good marker for CHD, a number of elevations (>3.0 mg/L) would signify a problem. ZRT Laboratories is a place to get a simple, in-home test (Cardio/Hormone Risk Test) that uses blood spot and saliva to test not only for CRP, but a number of other coronary risk factors as well as hormone levels.

What would cause an elevation in inflammatory markers? Toxicity is one so testing for urinary markers of petrochemicals which is done only by US Biotek, is a good place to start. By seeing if you are excreting chemicals like benzene, styrene, xylene, toluene, phthalates or parabens, you can find out where your exposures might be coming from. Another good test to run is a Hair Elements test from Doctor’s Data to determine possible heavy metal exposure. To help you better understand the report, I suggest Dr. Andrew Cutler’s book – Hair Test Interpretation: Finding Hidden Toxicities.

Another source of inflammatory triggers is food and the best test I have ever found in determining which foods can cause inflammation is the LEAP MRT. Developed by Signet Diagnostics, it can pinpoint the foods that cause the body to release pro-inflammatory prostaglandins, leukotrienes and cytokines that drive the inflammation process. It was the one test that helped my daughter control her seizure activity as well as behavioral issues. It has a great track record in relieving irritable bowel syndrome as well as migraines, both driven by inflammatory triggers.

If you want to become heart healthy, you need to find out whether your body is inflammed and if so, what is causing it. Once you do that, you reduce your risk of developing not just heart disease, but a number of other health conditions.

Cholesterol Lowering Drugs are Worthless in Most Cases – Part Two

This past Friday, I talked about the issues with Lipitor® and the lack of the association between high cholesterol and coronary heart disease. Now let’s talk about real problems that comes up by taking this drug.

Say the side-effect rate is 3-5% (which is the pharmaceutical industry line) which means that given one-percent of people get a benefit, five-percent get side-effects that can be rather serious. Guess what? That estimate is way under what practitioners in the field are seeing. Reports indicate that in the real world the side-effect rate is closer to 15%.

Obviously, this would mean that we need to move away from pharmaceutical intervention to lower cholesterol to alternative, “natural” ones right? Wrong. Turns out cholesterol levels in people with heart disease are not really much higher than people without heart disease. Also, low cholesterol (under 160mg/dl) may increase the risk of a number of health disorders like stroke, cancer, depression, and suicide. Lowering cholesterol is not the issue, in spite of what the nutraceutical industry would like you to believe. They are being no different in their claims than the pharmaceutical industry.

The real culprit in heart disease is inflammation. Lower inflammation and not only do you lower the real risk for heart disease , you lower the risks for a myriad of other diseases from diabetes to arthritis, from cancer to migraines, seizures and irritable bowel syndrome to name a few.

In tomorrow’s blog, I will discuss tools that will help you determine your level of inflammation along with things you can do to alleviate it.